AU2002239468A1 - Conjugates of an antioxidants with metal chelating ligands - Google Patents

Conjugates of an antioxidants with metal chelating ligands

Info

Publication number
AU2002239468A1
AU2002239468A1 AU2002239468A AU3946802A AU2002239468A1 AU 2002239468 A1 AU2002239468 A1 AU 2002239468A1 AU 2002239468 A AU2002239468 A AU 2002239468A AU 3946802 A AU3946802 A AU 3946802A AU 2002239468 A1 AU2002239468 A1 AU 2002239468A1
Authority
AU
Australia
Prior art keywords
conjugates
antioxidants
metal chelating
chelating ligands
ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002239468A
Other languages
English (en)
Inventor
Helen Fan
Ramachandra S. Ranganathan
Michael F. Tweedle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bracco International BV
Original Assignee
Bracco International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco International BV filed Critical Bracco International BV
Publication of AU2002239468A1 publication Critical patent/AU2002239468A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/0412—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K51/0419—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002239468A 2000-10-31 2001-10-31 Conjugates of an antioxidants with metal chelating ligands Abandoned AU2002239468A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24454700P 2000-10-31 2000-10-31
US60/244,547 2000-10-31
PCT/US2001/046002 WO2002040060A2 (fr) 2000-10-31 2001-10-31 Conjugues d'antioxydants et de ligands de chelation metallique destines a des applications diagnostiques et therapeutiques

Publications (1)

Publication Number Publication Date
AU2002239468A1 true AU2002239468A1 (en) 2002-05-27

Family

ID=22923208

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002239468A Abandoned AU2002239468A1 (en) 2000-10-31 2001-10-31 Conjugates of an antioxidants with metal chelating ligands

Country Status (5)

Country Link
EP (1) EP1406669A2 (fr)
JP (1) JP2004526671A (fr)
AU (1) AU2002239468A1 (fr)
CA (1) CA2421182A1 (fr)
WO (1) WO2002040060A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0305422D0 (en) 2003-03-10 2003-04-16 Univ Open Detection, monitoring and treatment of cancer
EP1466629A1 (fr) * 2003-04-11 2004-10-13 BRACCO IMAGING S.p.A. Produits d'addition entre reactifs pour RNM et substrats contenant des protons èchangeables pour des applications "CEST"
US8986650B2 (en) 2005-10-07 2015-03-24 Guerbet Complex folate-NOTA-Ga68
CA2625196C (fr) * 2005-10-07 2016-04-05 Guerbet Composes comprenant une partie de reconnaissance d'une cible biologique, couplee a une partie de signal capable de complexer le gallium
FR2942227B1 (fr) 2009-02-13 2011-04-15 Guerbet Sa Utilisation de tampons pour la complexation de radionucleides
FR2968999B1 (fr) 2010-12-20 2013-01-04 Guerbet Sa Nanoemulsion de chelate pour irm
FR2980364B1 (fr) 2011-09-26 2018-08-31 Guerbet Nanoemulsions et leur utilisation comme agents de contraste
DE102012208375B4 (de) * 2012-05-18 2015-07-23 Zentralklinik Bad Berka Gmbh Satz und Verfahren zur Herstellung eines Radiopharmakons
FR3001154B1 (fr) 2013-01-23 2015-06-26 Guerbet Sa Magneto-emulsion vectorisee
KR101603699B1 (ko) * 2014-01-10 2016-03-15 경북대학교 산학협력단 Do3a-아미노메틸사이클로헥산 콘쥬게이트를 포함하는 가돌리늄 착물
WO2020007822A1 (fr) 2018-07-02 2020-01-09 Conservatoire National Des Arts Et Metiers (Cnam) Nanoparticules de bismuth métallique (0), procédé de fabrication et utilisations de celles-ci

Also Published As

Publication number Publication date
CA2421182A1 (fr) 2002-05-23
WO2002040060A3 (fr) 2003-12-31
EP1406669A2 (fr) 2004-04-14
WO2002040060A2 (fr) 2002-05-23
JP2004526671A (ja) 2004-09-02

Similar Documents

Publication Publication Date Title
AU2001285446A1 (en) Called party billing
GB2370322B (en) Metallic seal components
GB2361508B (en) Metallic seal
AU2001261456A1 (en) Montage for an electronic market
AU2001231752A1 (en) Cook-top
AUPQ556600A0 (en) Electronic funds transfers-zipfund
AU2001245286A1 (en) Gearshift assembly
AU2001251575A1 (en) Curling iron shield
GB2370323B (en) Alternative metallic seals
EP1099781A3 (fr) Elément conducteur de polarisation pour le dépôt de métal
AU2002239468A1 (en) Conjugates of an antioxidants with metal chelating ligands
GB0105255D0 (en) Terminal assembly
AU2001290074A1 (en) Metal detector
GB2358526B (en) Metal terminal
AU2001286366A1 (en) Shielded housing
AU2002348913A1 (en) Cool-zone iron
AU2002222373A1 (en) Self-cleaning iron
AU2002316293A1 (en) Magnetic shield
AU2001228689A1 (en) Distortion reduction
AU3762001A (en) Soldering flux
AU5548900A (en) Soldering flux
AU2001231450A1 (en) Roundness standard
AU2001220118A1 (en) Metal component carrier
AU2001293749A1 (en) Magnetic component
AU2001250569A1 (en) An account